As medical authorities in Sweden, Finland, and the U.K. have moved away from the use of puberty blockers, cross-sex hormones, and surgery as a first-line treatment for gender dysphoria in minors, the United States has become increasingly isolated as a purveyor of “gender-affirming care.” The Biden administration, medical groups like the American Academy of Pediatrics (AAP), progressive political organizations like the American Civil Liberties Union, and high-profile activists have joined forces to disseminate misinformation on the issue. Evidence supporting the use of the controversial protocol for youths is, at best, extremely weak, yet its advocates continue to overstate its benefits, conceal its risks, and thwart meaningful discussion of its alternatives.